Why Modern Enterprises Choose Drupal
More Than a CMS. A Composable Digital Experience Platform.
When your digital needs outgrow basic templates and rigid systems, you need a platform engineered for flexibility, scalability, and integration. Drupal is the open-source powerhouse chosen by global enterprises to build digital experiences that are secure, adaptable, and built to last.
Recent releases
|
Lifecycle Marketing in Pharma: Turning Campaign Spend Into Compounding Value
Think about your last big campaign. You spent crores on creative, media, rep detailing, webinars. The numbers spiked. For a few weeks, it felt like traction. And then, a flatline. Doctors moved on,…
|
Pharma CRM Silos breaking alignment in healthcare marketing
Pharma CRM Silos block coordination between reps and digital teams, leading to poor doctor engagement, compliance risks, and lost prescriptions over time.
|
Doctor Learning Communities transforming medical education
Doctor Learning Communities replace static medical decks with interactive, compliant platforms that keep doctors engaged, foster trust, and drive lasting value.
|
Pharma Marketing Execution turning ideas into real outcomes
Pharma marketing doesn’t fail because of weak ideas. It fails because execution breaks down. In a regulated, crowded, and compliance-heavy industry, even the smartest campaign can collapse without…
CASE STUDY
See all our work
How a Top Indian Pharma Brand Boosted HCP Engagement Using Tech-Led Omnichannel Marketing
India’s renowned pharmaceutical company, known for its strong presence in chronic therapy areas, was facing a growing disconnect with its most important audience: healthcare professionals.
How a Leading Indian Pharma Brand Expanded Reach Across Semi-Urban & Rural Regions
A leading pharmaceutical company in India, well known for its OTC presence and deep connection with mass-market audiences, was preparing to launch a public awareness campaign focused on maternal he
Driving Digital Engagement for a Chronic Care Program with Tech-Led Pharma Marketing
A leading pharmaceutical company in India, known for its chronic care drug portfolio, was preparing to launch a support program aimed at patients diagnosed with congestive heart failure (CHF).
